Skip to content

The Effectiveness of the Psychological Care of AI Emotional Companion Assistants Among Patients With Advanced Cancer

The Effectiveness of the Psychological Care of AI Emotional Companion Assistants Among Patients With Advanced Cancer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07793084
Acronym
AI Cancer
Enrollment
50
Registered
2026-08-28
Start date
2024-11-04
Completion date
2025-12-31
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Keywords

Advanced Cancer, AI

Brief summary

Psychological issues in patients with advanced cancer are frequently overlooked, resulting in delayed or insufficient treatment. Current interventions are often limited by constraints related to space, location, and manpower, underscoring the need for accessible and feasible alternatives. This study examines the use of an AI emotional companion assistant and hypothesizes that, compared with the control group, the intervention group will experience improvements in depression, anxiety, and demoralization, along with enhanced quality of life and sleep quality. The study also aims to explore patients' experiences of interacting with the system.

Interventions

DEVICEAI Emotional Companion Assistants

The mobile application engages participants through a virtual character that conducts interactive conversations. The system integrates Azure OpenAI, speech synthesis, and emotion recognition technologies, enabling the virtual character to understand users' emotional states and provide empathetic support. When emotional instability is detected, the system proactively asks whether the user would like to speak with a real person and offers referral to a 24-hour human support hotline. After each conversation, the system conducts emotion analysis based on voiceprints and dialogue content, categorizing emotions into four types: happiness, fear, anger, and sadness. It also generates an emotional reflection summary and provides relevant action-oriented guidance. Additionally, the system features a "Guided Visualization World" that offers relaxing music and positive affirmations to enhance emotional well-being.

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* (1) Patients diagnosed with advanced cancer; (2) A score of 6 or higher on the Brief Symptom Rating Scale (BSRS-5); (3) Aged between 20 -65 years old; (4) Ability to communicate in Chinese; (5) Ownership of a smartphone with internet access and the ability to use it; (6) Willingness to participate in the study.

Exclusion criteria

* (1) Individuals determined by a physician to have suicidal ideation or tendencies; (2) A score of 2 or higher on the last item (suicidal thoughts) of the BSRS-5 scale; (3) Unable to communicate verbally.

Design outcomes

Primary

MeasureTime frameDescription
Change in Depression SeverityFrom enrollment to the end of intervention at 12 weeks. Post-test is held at 6 weeks, 12 weeks and 24 weeks after intervention.Change in Depression Severity: Depression severity will be assessed using a standardized depression scale. Scores will be analyzed as continuous variables. Unit of Measure: Scale score (e.g., 0-27) Interpretation: \<5 = normal 5-9 = mild 10-14 = moderate 15-19 = moderately severe ≥20 = severe
Change in Anxiety SeverityFrom enrollment to the end of intervention at 12 weeks. Post-test is held at 6 weeks, 12 weeks and 24 weeks after intervention.Anxiety Severity will be assessed using a standardized anxiety scale. Scores will be analyzed as continuous variables. Unit of Measure: Scale score (e.g., 0-21) Interpretation: \<5 = normal 5-9 = mild 10-14 = moderate ≥15 = severe
Change in Demoralization SeverityFrom enrollment to the end of intervention at 12 weeks. Post-test is held at 6 weeks, 12 weeks and 24 weeks after intervention.Demoralization severity will be assessed using a standardized demoralization scale. Scores will be analyzed as continuous variables. Unit of Measure: Scale score (e.g., 0-96) Interpretation: ≥30 = high

Secondary

MeasureTime frameDescription
Change in Quality of LifeFrom enrollment to the end of intervention at 12 weeks. Post-test is held at 6 weeks, 12 weeks and 24 weeks after intervention.Quality of life will be assessed using a standardized quality of life scale. Scores will be analyzed as continuous variables. Unit of Measure: Scale score (e.g., 0-108) Interpretation: Higher scores indicate better quality of life.
Change in Sleep QualityFrom enrollment to the end of intervention at 12 weeks. Post-test is held at 6 weeks, 12 weeks and 24 weeks after intervention.Sleep quality will be assessed using a standardized sleep scale. Scores will be analyzed as continuous variables. Scale score (e.g., 0-21) Interpretation: 0-3 = normal 4-5 = suspected insomnia ≥6 = probable insomnia

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026